BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Corsi-Zuelli F, Marques L, da Roza DL, Loureiro CM, Shuhama R, Di Forti M, Menezes PR, Louzada-Junior P, Del-Ben CM. The independent and combined effects of cannabis use and systemic inflammation during the early stages of psychosis: exploring the two-hit hypothesis. Psychol Med 2021;:1-11. [PMID: 33736715 DOI: 10.1017/S0033291721000726] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Ibarra‐lecue I, Unzueta‐larrinaga P, Barrena‐barbadillo R, Villate A, Horrillo I, Mendivil B, Landabaso MA, Meana JJ, Etxebarria N, Callado LF, Urigüen L. Cannabis use selectively modulates circulating biomarkers in the blood of schizophrenia patients. Addiction Biology 2022;27. [DOI: 10.1111/adb.13233] [Reference Citation Analysis]
2 Romeo B, Lestra V, Martelli C, Benyamina A, Hamdani N. Cannabis Cessation, Inflammatory Markers and Schizophrenia. J Dual Diagn 2022;:1-9. [PMID: 34985404 DOI: 10.1080/15504263.2021.2013697] [Reference Citation Analysis]
3 Corsi-Zuelli F, Deakin B, de Lima MHF, Qureshi O, Barnes NM, Upthegrove R, Louzada-Junior P, Del-Ben CM. T regulatory cells as a potential therapeutic target in psychosis? Current challenges and future perspectives. Brain Behav Immun Health 2021;17:100330. [PMID: 34661175 DOI: 10.1016/j.bbih.2021.100330] [Reference Citation Analysis]